Average Co-Inventor Count = 12.00
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bioverativ Therapeutics Inc. (4 from 71 patents)
2. Biogen Idec Hemophilia Inc. (1 from 5 patents)
3. Biogen Hemophilia Inc. (1 from 2 patents)
6 patents:
1. 12186375 - Factor VIII chimeric and hybrid polypeptides, and methods of use thereof
2. 11266720 - Factor VIII-FC chimeric and hybrid polypeptides, and methods of use thereof
3. 10881742 - Factor VIII chimeric and hybrid polypeptides, and methods of use thereof
4. 10010622 - Factor VIII chimeric and hybrid polypeptides, and methods of use thereof
5. 9241978 - Factor VIII-Fc chimeric and hybrid polypeptides, and methods of use thereof
6. 9050318 - Factor VIII-Fc chimeric and hybrid polypeptides, and methods of use thereof